| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/14/2011 | US20110171193 Compositions and methods for treating pulmonary hypertension |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171181 Methods for modifying vascular vessel walls |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171159 Glycoside Derivatives and Uses Thereof |
| 07/14/2011 | US20110171136 Optical imaging probes |
| 07/14/2011 | US20110171133 Radiolabelled mmp selective compounds |
| 07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
| 07/14/2011 | CA2786534A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/14/2011 | CA2786527A1 Biomatrices to attract and retain regenerative and reparative cells |
| 07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
| 07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
| 07/14/2011 | CA2784118A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 07/14/2011 | CA2784028A1 Method of treating atrial fibrillation |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343076A1 Pharmaceutical composition for oral administration |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343063A1 Pharmaceutical preparations comprising a COS releasing compound |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2343060A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/13/2011 | EP2342341A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| 07/13/2011 | EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/13/2011 | EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 07/13/2011 | EP2341913A1 Method of enhancing tgf-beta signalling |
| 07/13/2011 | EP2051717B1 Replacing heart surgery by micronutrient |
| 07/13/2011 | EP1965831B1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 07/13/2011 | EP1934245B1 Y2 selective receptor agonists for therapeutic interventions |
| 07/13/2011 | EP1733723B1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1265878B1 A process for the preparation of epothilone analogs and intermediates |
| 07/13/2011 | CN1981816B Chinese-medicinal composition for treating ischemic heart disease, its preparation and use |
| 07/13/2011 | CN1919249B Chinese traditional medicine for treating cardiovascular and cerebrovascular disease |
| 07/13/2011 | CN1919245B Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 07/13/2011 | CN1919242B Traditional Chinese medicine composition for treating cardiac and cerebral vascular disease |
| 07/13/2011 | CN102124010A Isosorbide nitrates having vasodilating activity |
| 07/13/2011 | CN102123763A Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 07/13/2011 | CN102123720A Extract from oil palm leaves comprising phenolic acids |
| 07/13/2011 | CN102123711A Treatment of pulmonary arterial hypertension |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120764A Angiogenesis of triple mutant low-oxygen inducible factor 1 alpha induced by auxiliary activating factors and application thereof |
| 07/13/2011 | CN102120752A Compound with effects of resisting inflammation and platelet activation and aggregation as well as preparation method and application thereof |
| 07/13/2011 | CN102120746A Clopidogrel hydrochloride crystal form II as well as preparation method and application thereof |
| 07/13/2011 | CN102120745A Crystal form I of clopidogrel hydrochloride and preparation method and application thereof |
| 07/13/2011 | CN102120744A Optical-activity 2-hydroxytetrahydrothienopyridine derivative, preparation method and application thereof in pharmacy |
| 07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
| 07/13/2011 | CN102120035A Novel targeted medicament for treating metabolic syndrome by targeting at white adipose tissues |
| 07/13/2011 | CN102120009A Prunella vulgaris capsule capable of stabilizing blood pressure |
| 07/13/2011 | CN102120001A Jiuhua hemorrhoid suppository and preparation method thereof |
| 07/13/2011 | CN102119984A Preparation method and application of carthamus tinctorius L. active ingredient containing hydroxysafflor yellow A |
| 07/13/2011 | CN102119981A Chinese herbal medicine tea bag for reducing blood pressure and preventing stroke |
| 07/13/2011 | CN102119971A Traditional Chinese medicine for treating coronary heart disease |
| 07/13/2011 | CN102119965A Extract for preventing and treating angina pectoris and preparation method and application thereof |
| 07/13/2011 | CN102119964A Extract of preventing and treating coronary heart disease and stenocardia and preparation method and application thereof |
| 07/13/2011 | CN102119963A Extract for preventing and treating angina pectoris and coronary heart disease and preparation method and application thereof |
| 07/13/2011 | CN102119962A Extract for preventing and treating angina pectoris and preparation method and application thereof |
| 07/13/2011 | CN102119961A Detection method of compound danshen dripping pills |
| 07/13/2011 | CN102119960A Medicinal composition for activating blood, dissolving stasis, tonifying qi and freeing vessels |
| 07/13/2011 | CN102119959A Preparation for adjusting blood pressure and blood fat and preventing cardiovascular and cerebrovascular diseases and preparation method thereof |
| 07/13/2011 | CN102119957A Preparation method and application of effective ingredient of rosewood heart wood |
| 07/13/2011 | CN102119948A Carthamus tinctorius L. active ingredient with myocardial protection function and preparation method and application |
| 07/13/2011 | CN102119947A Preparation method and application of carthamus tinctorius L. active ingredient |
| 07/13/2011 | CN102119946A Pseudo-ginseng effective ingredient and preparation method and application thereof |
| 07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
| 07/13/2011 | CN102119943A Moringa oil emulsion |
| 07/13/2011 | CN102119936A Method for preparing injection for treating ischemic brain damage by using human amniotic mesenchymal cells and injection |
| 07/13/2011 | CN102119935A Application of tunicamycin in preparing medicament for treating ischemic cerebral apoplexy |
| 07/13/2011 | CN102119930A Olmesartan medoxomil tablets and preparation method thereof |
| 07/13/2011 | CN102119928A Preparation method of lumbrokinase enteric-coated pellets |
| 07/13/2011 | CN102119926A Valsartan self-emulsifying medicament transfer system and preparation method thereof |
| 07/13/2011 | CN102119925A Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 07/13/2011 | CN102119920A Edaravone injection and preparation method thereof |
| 07/13/2011 | CN101589898B Multifunctional health care Chinese medicament pillow |
| 07/13/2011 | CN101496813B Applicance of combination in drug coating of preparing anti-hyperblastosis (vascular restenosis) support |
| 07/13/2011 | CN101461900B Pure medicinal formulation for treating arteriosclerosis |
| 07/13/2011 | CN101396543B Pure traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
| 07/13/2011 | CN101396498B Traditional Chinese medicine preparation for treating cerebrovascular disease |
| 07/13/2011 | CN101301267B Bilobalide B injection and preparation thereof |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/13/2011 | CN101085295B Freeze dried injection containing muskone and preparation method thereof |
| 07/13/2011 | CN101085188B Method for preparing total saponins of radix ophiopogonis |
| 07/13/2011 | CN101084950B Traditional Chinese medicinal composition containing red sage root, notoginseng, radix astragali and musk or muscone and preparation |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977350 CCR1 antagonists and methods of use therefor |
| 07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977310 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 07/12/2011 | US7977065 Yeast strains autonomously producing steroids |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2526534C Compounds and methods for delivery of prostacyclin analogs |
| 07/12/2011 | CA2500649C Substituted arylhexadienoic acids and esters thereof, their use in the treatment of dyslipidaemia, diabetes and atherosclerosis, and processes for their preparation |